Noticias y eventos de P3 Health Partners Inc (PIII)

$8.890

-0.167 (-1.88%)Al cierre

Noticias de PIII

9.508-11NASDAQ.COM

P3 Health Partners Reports Revenue Growth and Profitability in Q2 2026

8.505-28NASDAQ.COM

Q32 Bio Soars Over 85% on $55 Million Private Placement Announcement

2.005-22NASDAQ.COM

Multiple Companies Experience Significant Stock Price Gains

9.505-15seekingalpha

P3 Health Partners Reports Strong Q1 2026 Earnings and Raises Outlook

9.505-14seekingalpha

P3 Health Partners Q1 Earnings Beat Expectations

9.503-26seekingalpha

P3 Health Partners Q4 Earnings Report Analysis

7.003-26moomoo

P3 Health Partners Inc. Projects Total Revenue Between $1.5 Billion and $1.7 Billion for 2026

9.503-26moomoo

P3 Health Partners Reports Results for Fourth Quarter and Full Year 2025

9.503-13Newsfilter

P3 Health Partners to Release 2025 Financial Results on March 26, 2026

7.512-02Newsfilter

P3 Health Partners Forms Joint Venture with Commonwealth to Expand Value-Based Care

Ver más noticias

Eventos de PIII

8/10 16:30

Sees FY26 Adjusted EBITDA of $80M-$110M

Sees FY26 adjusted EBITDA $80M-$110M.

8/10 16:30

P3 Reports Q2 Revenue of $386.38M, Beating Expectations

Reports Q2 revenue $386.38M, consensus $377.95M. "Q2 demonstrates that the business is now executing according to our plan. We delivered $54 million of adjusted EBITDA, with the core business driving improved profitability quarter over quarter. Our results reflect the structural improvements now embedded across our contracts, our network, and our operating model, the work I outlined at the onset of my tenure. That strength gives us the confidence to raise our full-year 2026 adjusted EBITDA outlook and to enter the second half focused on execution," said Dr. Aric Coffman, CEO of P3.

5/19 10:00

P3 Health Partners Inc Trading Resumes

P3 Health Partners Inc trading resumes

5/19 09:50

P3 Health Partners Inc Trading Halted Due to Volatility

P3 Health Partners Inc trading halted, volatility trading pause

5/14 16:20

Sees FY26 Adjusted EBITDA of $20M-$60M

Sees FY26 adjusted EBITDA $20M-$60M

Ver más eventos

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.